Mike Glennon

Michael J. Glennon has been President and CEO of Saphena Medical since July 2013. He has taken the Venapax system from concept through design development, regulatory processes, FDA clearance and into the market.

Previously, Mike was instrumental in the launch and rapid growth of VasoView, the first endoscopic vessel harvesting technology, which became the standard of care in coronary bypass surgery.

Mr. Glennon was the President and Chief Executive Officer of Vortex Medical from its inception in 2008 until its acquisition in October 2012 by AngioDynamics.

He has served as a co-founding Partner of both Pavilion Holdings Group, a medical device holding company, and Pavilion Medical Innovations, a venture-backed medical device incubator, since their respective inceptions in 2007 and 2009 and also serves as Chairman and Chief Executive Officer of PMI.

In addition to his responsibilities at Saphena, he has been the President and Chief Executive Officer of Cruzar Medsystems since July 2013 and has served as a director of Kaleidoscope Medical since January 2013. He has been Vice Chairman and a Director at PAVmed since October 2014.

Mr. Glennon received his B.S. in Business Administration from the University of New Hampshire.